One in six men will be diagnosed with prostate cancer during his lifetime, the second leading cause of death among men in the United States. It’s a serious problem and current diagnostic tests aren’t very specific. But a research team at the University of Central Florida NanoScience Technology Center has found a more accurate test that not only determines whether a patient has prostate cancer, but also how aggressive it is.
